157 related articles for article (PubMed ID: 9691109)
1. Bisphosphonates as anticancer drugs.
Mundy GR; Yoneda T
N Engl J Med; 1998 Aug; 339(6):398-400. PubMed ID: 9691109
[No Abstract] [Full Text] [Related]
2. Should oral bisphosphonates be standard of care in women with early breast cancer?
Clemons M; Verma S
Breast Cancer Res Treat; 2005 Apr; 90(3):315-8. PubMed ID: 15830146
[TBL] [Abstract][Full Text] [Related]
3. Aredia: the once-monthly infusion for the treatment of bone metastases.
Lipton A
Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S1-5. PubMed ID: 9801852
[TBL] [Abstract][Full Text] [Related]
4. Clodronate in metastatic breast cancer.
Meli M; Rausa L
N Engl J Med; 1998 Dec; 339(26):1940; author reply 1941. PubMed ID: 9874607
[No Abstract] [Full Text] [Related]
5. [Bisphosphonates in the treatment and prevention of bone metastases].
Hoekman K; van Holten-Verzantvoort AT; Pinedo HM
Ned Tijdschr Geneeskd; 1997 Nov; 141(46):2217-22. PubMed ID: 9550782
[TBL] [Abstract][Full Text] [Related]
6. Clodronate in metastatic breast cancer.
Panasci LC; Sandor V; Melnychuk D
N Engl J Med; 1998 Dec; 339(26):1940-1; author reply 1941. PubMed ID: 9874608
[No Abstract] [Full Text] [Related]
7. [Diphosphonates in solid malignant tumors].
Kamby C; Pedersen L; Kristensen B
Ugeskr Laeger; 2005 Jan; 167(4):379-82. PubMed ID: 15719560
[No Abstract] [Full Text] [Related]
8. [Expanding the possibilities of using biphosphonates for prophylaxis and treatment of osteal complications in malignant metastasis].
Svishchenko IuA; Shimanovskiĭ NL
Eksp Klin Farmakol; 2004; 67(6):66-71. PubMed ID: 15707020
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates spearhead new approach to treating bone metastases.
Bankhead C
J Natl Cancer Inst; 1997 Jan; 89(2):115-6. PubMed ID: 8998176
[No Abstract] [Full Text] [Related]
10. Reduction in new metastases in breast cancer with adjuvant clodronate treatment.
Diel IJ; Solomayer EF; Costa SD; Gollan C; Goerner R; Wallwiener D; Kaufmann M; Bastert G
N Engl J Med; 1998 Aug; 339(6):357-63. PubMed ID: 9691101
[TBL] [Abstract][Full Text] [Related]
11. [Is pamidronate or clodronate better?].
Adam Z
Vnitr Lek; 2002 Apr; 48(4):357. PubMed ID: 12075601
[No Abstract] [Full Text] [Related]
12. [Bisphosphonates in the therapy of cancer patients].
Jantunen E; Kumpulainen E
Duodecim; 1999; 115(1):27-32. PubMed ID: 11830857
[No Abstract] [Full Text] [Related]
13. Bisphosphonates: lingering questions about their use.
Derrane M
J Natl Cancer Inst; 1998 Sep; 90(18):1329-31. PubMed ID: 9747862
[No Abstract] [Full Text] [Related]
14. [Bisphosphonates in the treatment of breast carcinoma].
Stajszczyk M; Mykała-Cieśla J
Pol Arch Med Wewn; 2001 Aug; 106(2):729-38. PubMed ID: 11926150
[No Abstract] [Full Text] [Related]
15. The role of bisphosphonates in the treatment of prostate cancer.
Parker CC
BJU Int; 2005 May; 95(7):935-8. PubMed ID: 15839907
[No Abstract] [Full Text] [Related]
16. Adjuvant bisphosphonates in breast cancer: are we witnessing the emergence of a new therapeutic strategy?
Coleman RE
Eur J Cancer; 2009 Jul; 45(11):1909-15. PubMed ID: 19447606
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates: preclinical review.
Green JR
Oncologist; 2004; 9 Suppl 4():3-13. PubMed ID: 15459425
[TBL] [Abstract][Full Text] [Related]
18. The evolving role of bone-conserving therapy in patients with breast cancer.
Brufsky AM
Semin Oncol; 2010 Jun; 37 Suppl 1():S12-9. PubMed ID: 20682367
[TBL] [Abstract][Full Text] [Related]
19. Use of bisphosphonates in cancer patients.
Body JJ; Coleman RE; Piccart M
Cancer Treat Rev; 1996 Jul; 22(4):265-87. PubMed ID: 9025784
[No Abstract] [Full Text] [Related]
20. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
Paterson AH; Kanis JA; Powles TJ; McCloskey E; Hanson J; Ashley S
Can J Oncol; 1995 Dec; 5 Suppl 1():54-7. PubMed ID: 8853526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
